Daclatasvir 30 mg/day is the correct dose for patients taking atazanavir/cobicistat

Smolders EJ, Colbers EP, de Kanter CT, et al. Daclatasvir 30 mg/day is the correct dose for patients taking atazanavir/cobicistat. Velthoven-Graafland K, Drenth JPH, Burger DM. J Antimicrob Chemother. 2017;72(2):486-489.

Publication Type:

Journal Article

Authors:

Smolders, E. J.; Colbers, EP; de Kanter, CT; et, al

Source:

J Antimicrob Chemother, Volume 72, Issue 2, p.486-489 (2017)

Keywords:

Adult, Anti-HIV Agents, Atazanavir Sulfate, Cobicistat, Cross-Over Studies, Cytochrome P-450 CYP3A Inhibitors, Female, HIV Infections, Humans, Imidazoles, Male, Middle Aged, Prospective Studies, ritonavir, Young Adult

Cited On:

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/27798211

Export Citation:
RIS Format
Top